|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 08, 2017 ) Publisher's Report, "Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Non-Hodgkin Lymphoma Report is to understand the market and pipeline status of the drugs around the Non-Hodgkin Lymphoma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Publisher's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Non-Hodgkin Lymphoma. While the leading brands, companies and chemicals are considered thoroughly, Publisher's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.
For more information http://www.reportsweb.com/non-hodgkin-lymphoma-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2017 .
Report Scope
- A snapshot of the global Market and Phase III therapeutics scenario for Non-Hodgkin Lymphoma.
- A review of the marketed products under prescription for Non-Hodgkin Lymphoma, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Non-Hodgkin Lymphoma with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Non-Hodgkin Lymphoma drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Non-Hodgkin Lymphoma drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Non-Hodgkin Lymphoma drugs.
- Coverage of Non-Hodgkin Lymphoma Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001544028/sample .
Table of content:
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Non-Hodgkin Lymphoma
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Non-Hodgkin Lymphoma
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Non-Hodgkin Lymphoma
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001544028/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
